LGT Capital Partners LTD. Trims Position in UnitedHealth Group Inc (UNH)
LGT Capital Partners LTD. decreased its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 36.8% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 83,720 shares of the healthcare conglomerate’s stock after selling 48,810 shares during the period. UnitedHealth Group makes up 1.7% of LGT Capital Partners LTD.’s holdings, making the stock its 21st biggest holding. LGT Capital Partners LTD.’s holdings in UnitedHealth Group were worth $20,856,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of UNH. TIAA CREF Investment Management LLC lifted its position in UnitedHealth Group by 7.3% during the 3rd quarter. TIAA CREF Investment Management LLC now owns 5,462,680 shares of the healthcare conglomerate’s stock valued at $1,453,291,000 after purchasing an additional 370,179 shares during the period. Financial Enhancement Group LLC lifted its position in UnitedHealth Group by 2,579.3% during the 3rd quarter. Financial Enhancement Group LLC now owns 1,554 shares of the healthcare conglomerate’s stock valued at $413,000 after purchasing an additional 1,496 shares during the period. Sawtooth Solutions LLC lifted its position in UnitedHealth Group by 34.4% during the 3rd quarter. Sawtooth Solutions LLC now owns 4,413 shares of the healthcare conglomerate’s stock valued at $1,174,000 after purchasing an additional 1,129 shares during the period. Bluefin Trading LLC acquired a new position in UnitedHealth Group during the 3rd quarter valued at about $578,000. Finally, AXA lifted its position in UnitedHealth Group by 5.7% during the 3rd quarter. AXA now owns 911,581 shares of the healthcare conglomerate’s stock valued at $242,517,000 after purchasing an additional 49,227 shares during the period. Institutional investors and hedge funds own 85.28% of the company’s stock.
In related news, Director Richard T. Burke sold 6,090 shares of the stock in a transaction that occurred on Wednesday, November 28th. The stock was sold at an average price of $281.72, for a total transaction of $1,715,674.80. Following the completion of the sale, the director now directly owns 1,711,584 shares of the company’s stock, valued at approximately $482,187,444.48. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Kenneth Irwin Shine sold 163 shares of the stock in a transaction that occurred on Friday, November 9th. The stock was sold at an average price of $274.83, for a total value of $44,797.29. The disclosure for this sale can be found here. 0.87% of the stock is currently owned by corporate insiders.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 EPS for the quarter, beating analysts’ consensus estimates of $3.30 by $0.11. The company had revenue of $56.56 billion during the quarter, compared to analysts’ expectations of $56.34 billion. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. UnitedHealth Group’s revenue was up 12.4% on a year-over-year basis. During the same period in the prior year, the business posted $2.66 EPS. As a group, research analysts anticipate that UnitedHealth Group Inc will post 12.81 earnings per share for the current year.
A number of research analysts have issued reports on UNH shares. Argus upped their target price on shares of UnitedHealth Group to $285.00 and gave the company a “buy” rating in a research report on Thursday, October 18th. Jefferies Financial Group upped their target price on shares of UnitedHealth Group from $270.00 to $311.00 and gave the company a “buy” rating in a research report on Wednesday, October 3rd. ValuEngine upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday, October 2nd. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $299.00 target price on the stock in a research report on Tuesday, September 25th. Finally, Bank of America upped their target price on shares of UnitedHealth Group from $315.00 to $320.00 and gave the company a “buy” rating in a research report on Wednesday, October 17th. One equities research analyst has rated the stock with a hold rating and twenty-three have given a buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $293.86.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/lgt-capital-partners-ltd-trims-position-in-unitedhealth-group-inc-unh/2745278.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Institutional Investors
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.